Mirae Asset Global Investments Co., Ltd. Evolus, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Evolus, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,869 shares of EOLS stock, worth $31,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,869
Previous 15,611
88.03%
Holding current value
$31,866
Previous $218,000
90.83%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding EOLS
# of Institutions
164Shares Held
49.1MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$98.1 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$82.6 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$68.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$50.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$49.6 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $956M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...